No association of the C677T methylenetetrahydrofolate reductase polymorphism with schizophrenia
- 1 October 2006
- journal article
- other
- Published by Wolters Kluwer Health in Psychiatric Genetics
- Vol. 16 (5) , 221-223
- https://doi.org/10.1097/01.ypg.0000242192.28526.fa
Abstract
Some serological and genetic studies have suggested that alterations in folate metabolism are associated with increased vulnerability to schizophrenia. In particular, these findings are most striking for the role of a putatively functional variant (C677T) in the methylenetetrahydrofolate reductase (MTHFR) gene. To test the hypothesis that the T allele and the TT genotype are risk factors for psychosis, we genotyped the C677T polymorphism in 206 participants with schizophrenia or schizoaffective disorder and 359 participants from a population control sample. Neither the T allele nor the TT genotype was associated with increased risk for schizophrenia. These results do not support a role for the C677T MTHFR variant in schizophrenia.Keywords
This publication has 9 references indexed in Scilit:
- Further evidence that hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T and A1289C polymorphisms are not risk factors for schizophreniaProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2005
- Association of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene with schizophrenia: Association is significant in men but not in womenProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2005
- Hyperhomocysteinemia, methylenetetrahydrofolate reductase 677TT genotype, and the risk for schizophrenia: A dutch population based case‐control studyAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2005
- A meta‐analysis of the MTHFR C677T polymorphism and schizophrenia riskAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2005
- Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: A preliminary reportAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2005
- Population-based association analyses of the HOPA12bp polymorphism for schizophrenia and hypothyroidismAmerican Journal of Medical Genetics, 2001
- The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia.Nature Structural & Molecular Biology, 1999
- Homocysteinemia and schizophrenia as a case of methylation deficiencyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1994
- Best Estimate of Lifetime Psychiatric DiagnosisArchives of General Psychiatry, 1982